chrisvoncsefalvay/vaers-outcomes huggingface dataset:
weak; fatigued; unable to get out of bed; unable to care for themself; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of FATIGUE (weak), FATIGUE (fatigued), ASTHENIA (unable to get out of bed) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (unable to care for themself) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced FATIGUE (weak), FATIGUE (fatigued), ASTHENIA (unable to get out of bed) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (unable to care for themself). At the time of the report, FATIGUE (weak), FATIGUE (fatigued), ASTHENIA (unable to get out of bed) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (unable to care for themself) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No Concomitant medications were provided. No Treatment history was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-037341 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-037341:
Noticed small hives on outer thigh, later spreading to other legs as day went on.  Gave Benadryl and called pediatrician.  Next day woke up covered on back and arms and went to pediatrician.  Advised to give Benadryl through the day.  Hives spread to face in evening and today, 23rd her body is still splotchy covered red.
Denies any adverse events.  Mother says child is doing great!  She took a 4 hour nap after her vaccination.  Mom states child's physician recommended that she go ahead and get the vaccine knowing she was too young.
Headache started day after vaccine received, as well as extreme fatigue. I also had little appetite. Those side effects lasted 2 weeks and 2 days.
11:30: Administered Hep A IM to left deltoid, child had seizure like activity and lasting approximately on about 30 seconds.  Immediately after pulling needle out, Child's school nurse and mom presented child referred to ER by school nurse for evaluation.  Child in school next morning.  Follow up call on pt who had a seizure like activity 30 sec. after receiving his first hep A shot. Mother stated her son tends to tense up when receiving his shots, which cause the seizures. Their doctor will have to determine whether her son recieved his next dose of hep A. As of now, he is doing jus fine.
Swollen lymph node in left breast. Painful, very swollen for 4 to 5 days, then slowly resolved over the next couple days. No doctor seen for this.   About one week after vaccination, i started to get headaches and feel dizzy on and off.  I did go to the hospital for this because I have never had anything like that happen before.
This spontaneous report as received from a medical assistant refers to patients of unknown age and gender. There were no concomitant medications, concurrent conditions and medical history reported. On an unknown dates, the patients were vaccinated with improperly stored RECOMBIVAX HB lot# reported as L0333423 exp. 13-SEP-2017 (dose, route and site of administration were not reported). There were no adverse effects reported. The temperature of the storage was 47 Fahrenheit degree for 135 minutes. There was no previous temperature excursion. The reporter was call because of a "data logger". No product quality issue was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Tred, achy, vomiting, no fever, unable to walk, bed ridden. Took Tylenol. Told to go to urgent care. Much better the next day.
A nurse reported a pt received a vaccine on 3/23/2000, on 4/26/2000 she developed an injection site reaction characterized by redness, warmth and indented skin. Pt recovered
Myocarditis with troponin I HS 31,561, wall motion abnormalities, LV dysfunction, Improved with high dose IV steroid.
pt recvd vax & 1 wk later exp a rash on chest (front & back),swollen eyes,& was itchy;sx resolved w/o treatment;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2013, the patient was inoculated with the ZOSTAVAX vaccine at an army hospital as recommended for routine adult health maintenance and for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. In 2016 the patient was treated at a medical center for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Additional information has been requested.
Cough; Fever; Headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Body aches) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Body aches). On 03-Feb-2021, the patient experienced COUGH (Cough). At the time of the report, COUGH (Cough), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Body aches) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow up was received on 20 Apr 2021. Outcome of events added.
Same day I experienced a sore arm (to be expected). Within 24 hours I still had a sore arm and body aches. Within 3 days I still had a sore arm and back pain in my mid back (never had any back pain before). Day 4-5 developed a tightening feeling on my chest. Back pain worsened on my left side and became more of a spasm/jabbing feeling. Day 6 developed shingles all on the left side of my torso from the front of my chest (on left breast), around the under side of my left breast all the way to the middle of my back.  The back pain is still there on the left side, like someone is putting an annoying pressure around where just under my shoulder blade is.  Today is day 9 after the vaccine and is the worst day so far in terms of pressure on my back, itchiness/soreness/pain of having shingles. The past 9 days I have been sleeping 10-12 hours (usually at 8 hours) and taking 1.5-3 hour naps in the afternoon. Energy level continues to be low.
PATIENT C/O FEELING DIZZY TO THE POINT OF PASSING OUT X30 MINUTES.
Information has been received from a physician concerning a patient of unknown age and gender. On an unknown date the patient was vaccinated with unspecified number of doses of GARDASIL (dose, strength, lot # and route were not reported). On 22-MAY-2015, the patient was in the office and received a dose of GARDASIL 9 (dose, strength, lot# and route were not reported). No adverse effects were reported. Additional information has been requested.
After 24 hours: Muscle aches, chills, headache, fatigue, stomach upset, soreness in injected area. After 48 hours: large (4? x 2?) area of redness around injection area.
Jeopardized immune system due to non-hodgins  lymphoma stage 4 cancer
Shot received approx. 11:45 am on 2/3/2021. No I?ll effects besides slight injection site pain in evening.  6am on 2/4/2021, slight headache, muscle ache, and dizziness.   11am, increased dizziness.     2pm, tiredness, dizziness, increased muscle pain. (2/4/21)  6pm, tiredness, no appetite, fell asleep in chair.   10pm, awoke chilled and with dizziness and went to bed.  Woke from sleep with difficulty breathing/catching a breath (2/5/21) and nauseous.  8am, chills, minor breathing issues, elevated temp (98.1) and headache. Slept upright until  1:30pm.
Initial literature full article received on 08-Apr-2019 regarding an unsolicited valid serious case. This case was linked to 2019SA111401, 2019SA111422, 2019SA106595, 2019SA111434, 2019SA111441, 2019SA111446  (same literature). Background: Anaphylaxis, a rare and potentially life-threatening hypersensitivity reaction, can occur after vaccination. Objective: We sought to describe reports of anaphylaxis after vaccination made to the Vaccine Adverse Event Reporting System (VAERS) during 1990-2016. Conclusion: Anaphylaxis after vaccination is rare and can occur among persons with no history of hypersensitivity. Most persons recover fully with treatment, but serious complications, including death, can occur. This case involves a 43 years old female patient who experienced anaphylactic reaction, while she received vaccines INFLUENZA VACCINE (QUADRIVALENT). The patient's past medical history included hypertension; depression; patient had no hypersensitivities. The patient's past medical treatment(s), vaccination(s) and family history were not provided. Concomitant therapy was not reported. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (QUADRIVALENT) produced by unknown manufacturer lot number not reported via unknown route in unknown site of administration. On an unknown date, within one day the patient developed a serious anaphylactic reaction with symptoms patches of urticaria, airway swelling increased (Respiratory tract oedema) and serum tryptase level increased following the administration of INFLUENZA VACCINE, (QUADRIVALENT). The event anaphylactic reaction was leading to death. Lab test included increased serum tryptase level. Final diagnosis was (fatal) anaphylactic reaction. It was not reported if the patient received a corrective treatment. Autopsy was performed and the cause of death was reported as anaphylactic reaction. Outcome for all the events was fatal. List of document held: none; Sender's Comments: This case is from a literature article concerning a 43-year-old female patient who died due to Anaphylactic Reaction followed by patches of urticaria and airway swelling following Morning after vaccination with INFLUENZA VACCINE (QUADRIVALENT). Time to onset is compatible. Past medical history included hypertension; depression but no hypersensitivities. Autopsy results confirming the cause of death was due to Anaphylactic Reaction. Further information with patient's medical condition at time of vaccination, clinical course of the events, laboratory results, concomitant therapy, family history including respiratory allergies, such as asthma and drug allergies are needed to reassess the role of vaccine.; Reported Cause(s) of Death: Anaphylactic reaction.
Narrative:  Pt experienced numbness, loss of hearing, and itchiness x 2 days after his first Pfizer vaccine on 2/16/21. Pt declined receiving 2nd vaccine on 4/29/21 due to fear of getting this reaction again. The pt did not have any respiratory issues.
After approximately 30 hours of receiving the Pneumovax 23 vaccine she stated she was extremely ill along with her arm getting gradually worse and her blood pressure dropped to 102/68. She had went to see her doctor on October 9,2019 and he put her on Keflex and she said she is slowly feeling a little better.
approx 2 wks p/vax pt had problems walking & using legs & crying when was able to get to feet; p/walking seemed better, but when sitting again had problems; no fever; seen by MD;
tingling in lips, chest compress, palpitations, irregular heartbeat, swollen lips, pressure in lungs, brain fog, extremities tingling, trouble breathing
hives; raised papular rash bilateral lower extremity; Pruritic rash; This is a spontaneous report from a contactable physician (patient). A 35-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 04Jan2021 14:00 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no known allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 05Jan2021 14:00, the patient experienced pruritic rash then on 06Jan2021 10:00, the patient experienced hives and raised papular rash bilateral lower extremity. No angioedema. No treatment was received for the adverse events. The patient underwent lab tests and procedures which included nasal swab was negative on 30Dec2020. It was reported that the patient has been tested for COVID-19 on an unspecified date since the vaccination. Outcome of the events was recovering. The events were considered non-serious.  Information on the lot/batch number has been requested.
Due for her 2nd dose last 13Feb2021 but due to inclement weather it was cancelled; Diarrhea; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced inappropriate schedule of product administration and diarrhoea.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 16-JAN-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced Inappropriate schedule of product administration. On 19-Feb-2021, the patient had rescheduled their second planned dose of mRNA-1273 for prophylaxis of COVID-19 infection and the patient experienced diarrhoea.   No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events Inappropriate schedule of product administration and Diarrhoea was unknown.; Reporter's Comments: This case concerns a female patient of unknown age who received their first of two planned doses of mRNA-1273 (Lot: 027L20A), reporting inappropriate schedule of product administration and diarrhea. Considering the event of diarrhea occurred more than 1 month after receiving their first of two planned doses of mRNA-1273, the event is assessed as unlikely related to mRNA-1273.
At 8 am on the morning of 10/10/23 dizziness (lasted most of the day), his eyes had trouble focusing (not too bad), but on Tuesday his eyes hurt. Area around eyes hurt. Tired, fatigued.
The issue I have is that my left arm where I was inocculated with Pfizer second shot is very weak. I have muscle pain and when I make a simple twist or movement hurts, it hurts as if something is dislocated. This occured after my second shot and I took some Tylenol to relieve the headache and muscle pain the second day, all other symptoms resolved except for this which I expected to go away within a couple of days but it is still lingering. I have no trauma on my left hand before this and know it is strictly related to my vaccination. One thing I remember is the person who gave me the shot said it didn't even bleed. My receipt shows DR as the name of the person who was in that day/not sure if it's the same person who administered it.
headache; cough; flu like symptoms; fatigue lasted for 5 days. She was in bed for 2 days.; This case was reported by a consumer via call center representative and described the occurrence of headache in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In October 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 weeks after receiving Shingrix, the patient experienced headache, cough, influenza-like symptoms, fatigue and bedridden. On an unknown date, the outcome of the headache, cough, influenza-like symptoms and bedridden were unknown and the outcome of the fatigue was recovered/resolved.   It was unknown if the reporter considered the headache, cough, influenza-like symptoms, fatigue and bedridden to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the vaccine 2 weeks ago. The patient reported experiencing headache, flu like symptoms, fatigue and cough.  The fatigue lasted for 5 days. She was in bed for 2 days. The reporter did not consent to follow up.
Mother states child had swollen leg next day was the middle shot and took child into ER, was told reaction was hives. Given Benedryl. ER report states vax site reaction, negative hives as stated by mother.
Received 2 vaccines in left lateral Thigh IM Pedvax Hib and Prevnar on 08/15/2005. developed redness, swelling, warmth, bruising in a 6cm x 4cm area of left thigh 08/16/2005 and subjective fever. mom treated with Ibuprofen 2-3 times daily PO. from 08/15 to 08/18. No fever in my office 08/18/2005 10:45. 6 x 4cm red area on left thigh with mild induration. no fever.
Pt had strep pneumo onoset of 9/29/03. Diagnosed as Bacteremia. He had 3 previous pneumococcal conjugate vaccinations. Possible vaccine failure, isolate sent to CDC.
Information has been received on 27-NOV-2018 regarding a case in litigation from a lawyer concerning a female patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 27-MAR-2014, a pharmacist at a pharmacy administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. On or about 08-DEC-2014, the patient was treated by a physician's assistant at a dermatology physician's office for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is unknown. The causality of the events is related. Additional information has been requested.
Directly after the vaccine, I felt weak, drained and dizzy. A few hours later I got chills and a fever and have had a high fever ever since. It is now Wednesday, 5 days later, and I still have a high fever and hives, even after going to the emergency room and being flushed with an IV.
Initial report was received from a health care professional on 30 August 2013 which involved a cluster of two patients (siblings). The other patient has been captured in case number 2013-09268. A female patient (age and date of birth not reported) had received a fifth dose injection of DTaP "some years ago" (manufacturer, lot number, route and site of administration unknown) and an unspecified amount of time later, the patient developed urticaria and lip swelling. It was unknown if the patient had any concurrent illness, pre-existing allergies or medical conditions. Outcome was recovered. No additional information was provided at the time of the event. Documents held by sender: None.
Information regarding Prevnar (pneumococcal 7-valent conjugate vaccine(diphtheria crml97 protein) injection) was received from a physician regarding a 6 month old pt who experienced a small, circular, blistering, a patchy rash (approximately 1") around the injection site. The pt received a dose on an unspecified date in 08/2004. Event Details: 1-2 days post immunization, a 6 month old pt developed a small, circular rash. A few days later the pt developed blistering, patchy rash (approximately 1") around the injection site. The reporter indicated that the pt has No Fever. The physician indicated that he would evaluated the child on 08/05/04. No additional information was available at the time of this report.
pt recvd a Heptavax series (FEB89, MAR89, JUN89) & tested neg 24JAN90; An Engerix-B booster was given 23APR91 & 23MAY91 it was determined that pt tested neg & remained a non-responder (see also EBU920089);
3 hours post innoculation,  sore throat with swollen glands, chills, shaking and a mild headache.  Shortly thereafter, started experiencing uncontrolled itching and my skin was bright red (flushed) from above pubic bone and up to top of my head. (nothing on lower extremities).  No fever (98.1) and no visible rash.   The itching became so uncontrollable, I took 25mg Benadryl and remained taking it every 4 hours until 1/21/21.  A very fine, red rash appeared on 1/20/21 in the early morning.   The rash was, mainly at my fatty areas, breasts, abdomen and hips, but the Benadryl helped to control the itching.  The Benadryl did not take away the itching entirely. As of this morning, the rash has faded, but i'm still itching, mildly, in my abdomen and out edges of my breasts. I am going to try to stop the Benadryl this morning and see how I do.  If not better, will go see my PCP.
I was having problems with breathing and shortness of breath. I felt like my heart was fluttering, I went to my lupus doctor bc I thought it was my lupus. He said because it as a heart issue he wanted it followed up. The PCP sent me to an urgent care where I was sent to an ER. At the ER they did an EKG, gave me some steroids and did some stress tests on my heart. The steroids did help with the chest pain and the flutters. I was put on 14 days of prednisone and eventually I felt completely better.
This spontaneous report was received from a nurse referring to unknown number of patients of unknown age and gender. The patients' pertinent medical history, drug reactions/allergies and concomitant medication were not reported. On 01-NOV-2016, the patients were vaccinated with improperly stored ROTATEQ orally, lot # M006111 with expiration date 18-NOV-2017, (dosage was not reported), which was exposed to temperature excursion (temperature: 51.3 degrees F, time frame: 1 hour) because of data logger. There was no previous temperature excursion. No product quality complaint was involved. This is one of the several reports from the same reporter. Additional information has been requested.
(first dose) Tenderness at injection site, subsequent joint and muscle pain (first 24 hours), lethargy (second 24 hours); (second dose) tenderness at injection site, much greater pain on right side of body (first 24 hours), nausea, fever, lose of appetite, greater lethargy which included sleeping for 20 hours following  the injection, dizziness (second 24 hours).  In both cases, symptoms were gone by third day. One dose of 25 mg Tramadol were taken to relieve pain after first injection, two doses of 25 mg Tramadol were taken to relieve pain after second injection.